Boiron SA (LON:0DTF)

Market Cap	286.81M -30.4%
Revenue (ttm)	426.91M -1.8%
Net Income	22.55M +35.2%
EPS	1.26 +35.2%
Shares Out	n/a
PE Ratio	13.09
Forward PE	n/a
Dividend	1.18 (7.14%)
Ex-Dividend Date	Jun 3, 2026

Volume	1
Open	19.75
Previous Close	19.90
Day's Range	19.75 - 19.75
52-Week Range	17.00 - 31.25
Beta	0.22
Analysts	n/a
Price Target	n/a
Est. Earnings	Apr 22, 2027

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices (in vitro diagnostics), dietary supplements, herbal remedies, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive l...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,623
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DTF

Financial Performance

In 2025, Boiron's revenue was 501.11 million, an increase of 2.78% compared to the previous year's 487.56 million. Earnings were 32.64 million, an increase of 187.96%.

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error